Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs

E-ISSN： 1875-533x|21|23|2599-2609

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.23, 2014-08, pp. : 2599-2609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 35-37

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1549-1559

Bentham Science Publishers

Access to resources Recommend Favorite

AMPA Receptor Potentiators for the Treatment of CNS Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 181-194

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders

By Taylor E.M.

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

Benzo- and Thienobenzo- Diazepines: Multi-target Drugs for CNS Disorders

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 630-647

Bentham Science Publishers

Access to resources Recommend Favorite